Cadele

Medicinal product

(Invented) name

Cadele

Active substance (s)

Levonorgestrelis

Strength

1,5 mg

Pharmaceutical form

tabletė

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

G03AD01, Levonorgestrel

Marketing authorisation holder

SIA Ingen Pharma, Latvija

Date of authorisation

2019-03-07

Date of renewal

2023-10-10

Documents

Cadele_tab_viešas_AR.pdf

4350 Cadele 1,5mg PCS PL 2024 08 02.docx

4350 Pakuotės lapelis 2024 08 02.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Levonorgestrelis	1,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
101095	87206	1087206	lizdinė plokštelė	N1		Nereceptinis	LT/1/19/4350/001	Tiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2023-10-10	Perregistruotas
2019-03-07	Registruotas